IDXX today
$702.49-$0.10 (-0.01%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minBearish
5 minConsolidating
Daily trend turns down below $500.61
Key levels
Resistance$769.98
Resistance$713.74
Support$666.14
Support$602.00
Latest news & SEC filings
NewsInsiders at IDEXX Laboratories sell a large amount of shares
SEC FilingIdexx Laboratories Inc filed an insider trading report (Form 4)
All IDXX news →About IDEXX Laboratories
IDEXX Laboratories develops, manufactures, and distributes diagnostic products and services for companion animals, livestock, poultry, and dairy, as well as water testing. Its main segments are Companion Animal Group (CAG), Water, and Livestock, Poultry and Dairy (LPD). Customers include veterinary practices, laboratories, and water utilities. It operates in the United States and internationally.
Based on the company's 10-K filed Feb 20, 2026.
Nasdaq · Healthcare
IDEXX LABORATORIES INC /DE (IDXX)
What Is the Price Target for IDXX?
SEPT Low Target
$627.00
SEPT Mid Target
$700.00
SEPT High Target
$810.00
Analyst Consensus
$700.00
Is IDXX a Buy or Sell Right Now?
Thesis
- •Revenue growing 10.4% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for IDXX.
Start Free Trial →Is IDXX Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$517.03
70
Moat Score
WIDE
7/9
Piotroski Score
24.1
Altman Z-Score
What Is Smart Money Doing with IDXX?
Insider Signal
SELLING
0 buys / 11 sells (90d)
Congress Signal
BUYING
2 buys / 4 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Underberg Sharon E. | officer | Buy | 8,906 | $2.6M | Nov 4, 2026 |
| Underberg Sharon E. | officer | Sale | 6,348 | $4.4M | Nov 4, 2026 |
| Underberg Sharon E. | officer | Sale | 1,503 | $1.0M | Nov 4, 2026 |
| Underberg Sharon E. | officer | Sale | 1,055 | $728K | Nov 4, 2026 |
| MAZELSKY JONATHAN JAY | director officer | Buy | 25,140 | $4.5M | Nov 4, 2026 |
| MAZELSKY JONATHAN JAY | director officer | Sale | 1,945 | $1.4M | Nov 4, 2026 |
| MAZELSKY JONATHAN JAY | director officer | Sale | 4,075 | $2.8M | Nov 4, 2026 |
| MAZELSKY JONATHAN JAY | director officer | Sale | 1,667 | $1.2M | Nov 4, 2026 |
| MAZELSKY JONATHAN JAY | director officer | Sale | 4,540 | $3.2M | Nov 4, 2026 |
| MAZELSKY JONATHAN JAY | director officer | Sale | 2,136 | $1.5M | Nov 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →IDXX Growth Story
Revenue YoY
10.4%
3yr Revenue CAGR
8.5%
EPS Growth YoY
22.59%
FCF Growth YoY
30.8%
Revenue Trend
STABLE
Dark Pool Trades for IDXX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for IDXX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:56:00 | $705.61 | 1,120 | $$790K | SELL |
| 17:35:02 | $706.24 | 2,000 | $$1.4M | BUY |
| 15:45:07 | $705.74 | 1,753 | $$1.2M | BUY |
| 15:41:25 | $706.53 | 1,326 | $$937K | BUY |
| 21:28:25 | $702.59 | 1,242 | $$873K | BUY |
5 dark pool trades shown · $$5.2M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for IDXX
PREVIEWSEPT Investing provides real-time options flow tracking for IDXX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $630 | Dec 18 | 36 | $$78.0K | 10 | REGULAR |
| CALL | $600 | Jan 15 | 64 | $$122.9K | 11 | FLOOR |
| CALL | $800 | Apr 16 | 155 | $$36.2K | 11 | SWEEP |
| CALL | $600 | Jan 15 | 64 | $$122.5K | 11 | SWEEP |
4 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for IDEXX LABORATORIES INC /DE (IDXX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →IDXX — frequently asked questions
What is IDXX stock price today?
IDEXX LABORATORIES INC /DE (IDXX) is at $702.49, down 0.01% (-$0.10) at the Nov 12, 2026 close.
Why is IDXX stock moving today?
Latest IDXX news — Nov 5, 2026: Insiders at IDEXX Laboratories sell a large amount of shares · Nov 5, 2026: Idexx Laboratories Inc filed an insider trading report (Form 4)
Why did IDXX stock move on Nov 2, 2026?
IDEXX Laboratories shares surged 7.46% to close at $671.64 after the company reported Q3 2026 earnings that beat Wall Street estimates, driven by higher testing frequency among older pets even as clinic visits slowed. Management also highlighted that roughly 25% of Q3 CancerDx orders came from customers outside its main reference labs, while the Covet platform's annual revenue run rate sits near $20 million and is growing at a strong double-digit pace.
What is the IDXX price target?
The average analyst price target for IDXX is $700.00, ranging from $627 to $810, based on 7 analysts. Latest: UBS maintains on Nov 3, 2026.
What do analysts rate IDXX?
Analyst ratings for IDXX: 0 Buy, 9 Hold, 0 Sell — consensus Hold.
Did IDXX beat earnings?
IDXX last reported on Nov 2, 2026: EPS $4.01 vs $3.73 expected — a beat of 7.5%.
What is IDXX's P/E ratio?
IDXX trades at a P/E of 47.1 vs a Healthcare average of 18.5.
Does IDXX pay a dividend?
IDXX does not currently pay a dividend.
What are IDXX support and resistance levels?
Support: $666.14, $602.00, $571.75. Resistance: $713.74, $769.98.
What are insiders doing with IDXX?
Insider activity: SELLING, 0 buys and 11 sells in the last 90 days.
What is the latest news on IDXX?
Nov 5, 2026: Insiders at IDEXX Laboratories sell a large amount of shares · Nov 5, 2026: Idexx Laboratories Inc filed an insider trading report (Form 4)